Passage of Pseudomonas aeruginosa in compromised mice.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMC 414582)

Published in Infect Immun on October 01, 1979

Authors

C D Cox

Articles by these authors

Isolation of an iron-binding compound from Pseudomonas aeruginosa. J Bacteriol (1979) 4.52

Iron uptake with ferripyochelin and ferric citrate by Pseudomonas aeruginosa. J Bacteriol (1980) 3.60

Gene network shaping of inherent noise spectra. Nature (2006) 3.25

Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1981) 3.00

Siderophore activity of pyoverdin for Pseudomonas aeruginosa. Infect Immun (1985) 2.84

Separate nitrite, nitric oxide, and nitrous oxide reducing fractions from Pseudomonas perfectomarinus. J Bacteriol (1971) 2.80

Oxygen uptake by Treponema pallidum. Infect Immun (1974) 2.79

A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med (1991) 2.73

Coordinate regulation of siderophore and exotoxin A production: molecular cloning and sequencing of the Pseudomonas aeruginosa fur gene. J Bacteriol (1993) 2.69

Role of pyocyanin in the acquisition of iron from transferrin. Infect Immun (1986) 2.53

Purification, ultrastructure, and composition of axial filaments from Leptospira. J Bacteriol (1969) 2.39

Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun (1985) 2.38

Effect of pyochelin on the virulence of Pseudomonas aeruginosa. Infect Immun (1982) 2.35

Catabolism of glucose and fatty acids by virulent Treponema pallidum. Infect Immun (1977) 2.07

Use of 2-aminoacetophenone production in identification of Pseudomonas aeruginosa. J Clin Microbiol (1979) 1.77

Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields. J Bacteriol (1982) 1.72

Siderophore-mediated iron acquisition from transferrin by Pseudomonas aeruginosa. Infect Immun (1986) 1.71

Intermediate energy metabolism of Leptospira. J Bacteriol (1969) 1.70

Ferric uptake regulator mutants of Pseudomonas aeruginosa with distinct alterations in the iron-dependent repression of exotoxin A and siderophores in aerobic and microaerobic environments. Mol Microbiol (1996) 1.69

Terminal electron transport in Treponema pallidum. Infect Immun (1977) 1.66

Studies on the isolation and growth of Leptospira from surface waters. Ann Soc Belges Med Trop Parasitol Mycol (1966) 1.59

Isolation and growth of Leptospira on artificial media. J Bacteriol (1966) 1.45

Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J Clin Invest (1992) 1.44

Mapping of mutations in Pseudomonas aeruginosa defective in pyoverdin production. J Bacteriol (1986) 1.43

Enzymatic activity of albumin shown by coelenterazine chemiluminescence. Luminescence (2012) 1.43

Copper-binding compounds from Methylosinus trichosporium OB3b. J Bacteriol (1998) 1.43

Iron reductases from Pseudomonas aeruginosa. J Bacteriol (1980) 1.40

Beta-oxidation of fatty acids by Leptospira. Can J Microbiol (1970) 1.40

Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun (1998) 1.38

Terminal electron transport in Leptospira. J Bacteriol (1969) 1.35

Growth of a water strain of Leptospira in synthetic media. Antonie Van Leeuwenhoek (1970) 1.29

Growth requirements of pathogenic Leptospira. Infect Immun (1973) 1.27

Synthesis and biological activity of pyochelin, a siderophore of Pseudomonas aeruginosa. J Bacteriol (1988) 1.24

Separation of soluble denitrifying enzymes and cytochromes from Pseudomonas perfectomarinus. Can J Microbiol (1973) 1.24

Isolation and characterization of Pseudomonas aeruginosa mutants requiring salicylic acid for pyochelin biosynthesis. J Bacteriol (1988) 1.24

Respiration and oxidative phosphorylation in Treponema pallidum. Infect Immun (1978) 1.23

Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. Am J Physiol (1998) 1.22

The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. Infect Immun (1999) 1.20

Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect Immun (1997) 1.19

Shape of Treponema pallidum. J Bacteriol (1972) 1.16

Possible role of bacterial siderophores in inflammation. Iron bound to the Pseudomonas siderophore pyochelin can function as a hydroxyl radical catalyst. J Clin Invest (1990) 1.14

Antigenic analysis of water forms of Leptospira. J Bacteriol (1968) 1.12

Quantitative assay for genus-specific leptospiral antigen and antibody. Appl Microbiol (1973) 1.12

Pyruvate oxidation by Treponema pallidum. Infect Immun (1979) 1.10

Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation. Infect Immun (1996) 1.09

Distribution of superoxide dismutase, catalase, and peroxidase activities among Treponema pallidum and other spirochetes. Infect Immun (1981) 1.05

Pyocyanin from Pseudomonas aeruginosa inhibits prostacyclin release from endothelial cells. Infect Immun (1995) 1.02

Pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury. Am J Physiol (1994) 0.97

Iron transport and serum resistance in Pseudomonas aeruginosa. Antibiot Chemother (1971) (1985) 0.95

Mutasynthesis of siderophore analogues by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1991) 0.94

Bacterial metabolic 'toxins': a new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology (2010) 0.94

Electron paramagnetic resonance studies on the nature of hemoproteins in nitrite and nitric oxide reduction. Biochim Biophys Acta (1971) 0.93

Glucose incorporation by Treponema pallidum. Infect Immun (1979) 0.93

The measurement of toluene dioxygenase activity in biofilm culture of Pseudomonas putida F1. J Microbiol Methods (2000) 0.88

Enzymatic degradation of H2O2 by Leptospira. Infect Immun (1978) 0.87

Assessment of structural features of the pseudomonas siderophore pyochelin required for its ability to promote oxidant-mediated endothelial cell injury. Arch Biochem Biophys (2001) 0.83

Binding of iron and inhibition of iron-dependent oxidative cell injury by the "calcium chelator" 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid (BAPTA). Biochem Pharmacol (1998) 0.82

Distribution of glucose incorporated into macromolecular material by treponema pallidum. Infect Immun (1981) 0.81

Effect of red blood cells on the growth of Porphyromonas endodontalis and microbial community development. Oral Microbiol Immunol (1998) 0.80

Pseudomonas aeruginosa clearance in mice: comparison of tissue, strain, and corticosteroid effects. Infect Immun (1984) 0.80

Influence of oxygen on respiration and glucose catabolism by Treponema pallidum. Infect Immun (1981) 0.80

Characterization of leptospiral catalase and peroxidase. Can J Microbiol (1980) 0.80

Growth stimulation of Porphyromonas endodontalis by hemoglobin and protoporphyrin IX. Oral Microbiol Immunol (2000) 0.80

Iron acquisition from Pseudomonas aeruginosa siderophores by human phagocytes: an additional mechanism of host defense through iron sequestration? Infect Immun (2000) 0.79

Genetic mapping and characterization of Pseudomonas aeruginosa mutants that hyperproduce exoproteins. J Bacteriol (1985) 0.78

Micellar solubilization of polynuclear aromatic hydrocarbons in coal tar-contaminated soils. Environ Sci Technol (1995) 0.78

Distribution and regulation of stochasticity and plasticity in Saccharomyces cerevisiae. Chaos (2010) 0.76

Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation in vitro. Blood Coagul Fibrinolysis (2002) 0.75

Porphyromonas endodontalis binds, reduces and grows on human hemoglobin. Oral Microbiol Immunol (2001) 0.75

A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm. Pharmacotherapy (2001) 0.75